Therapeutic Carbohydrate Reduction for T2D Remission

This FREE session covers the clinical evidence for therapeutic carbohydrate reduction (TCR) as a first-line option for T2D management and remission, including findings from the DiRECT trial, DiRECT-Aus, and the CSIRO 2-year RCT.

You'll explore current RACGP and Diabetes Australia guidelines, and understand the physiological rationale for why TCR works.

1.5 CPD points.

Register here.

Email Sam Schofield for more information.